Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025433127> ?p ?o ?g. }
- W2025433127 endingPage "1546" @default.
- W2025433127 startingPage "1541" @default.
- W2025433127 abstract "Activating mutations of Fms-like tyrosine kinase 3 (Flt3) are the most common genetic abnormalities found in acute myeloid leukemia (AML) and represent potential therapeutic targets. The novel Flt3 inhibitor KRN383 inhibited the autophosphorylation of Flt3 bearing internal tandem duplications (ITDs) and the Asp835Tyr (D835Y) point mutation with half-maximal inhibitory concentration (IC50) values of ≤5.9 and 43 nM, respectively. KRN383 also inhibited the proliferation of the ITD-positive cell lines with IC50 values of ≤2.9 nM. A single oral administration of 80 mg/kg of KRN383 eradicated ITD-positive xenograft tumors in nude mice and prolonged the survival of SCID mice carrying ITD-positive AML cells. The effectiveness of a single oral dose of KRN383 suggests that it has the potential to be used in a wide variety of clinical regimens, including multicycle and combination therapies." @default.
- W2025433127 created "2016-06-24" @default.
- W2025433127 creator A5002130016 @default.
- W2025433127 creator A5016021144 @default.
- W2025433127 creator A5017158232 @default.
- W2025433127 creator A5021542575 @default.
- W2025433127 creator A5034932811 @default.
- W2025433127 creator A5038129810 @default.
- W2025433127 creator A5042588749 @default.
- W2025433127 creator A5043017347 @default.
- W2025433127 creator A5045693486 @default.
- W2025433127 creator A5059619073 @default.
- W2025433127 creator A5062150969 @default.
- W2025433127 creator A5067804516 @default.
- W2025433127 creator A5084554077 @default.
- W2025433127 creator A5085709435 @default.
- W2025433127 creator A5087474480 @default.
- W2025433127 creator A5088372604 @default.
- W2025433127 creator A5076054400 @default.
- W2025433127 date "2006-12-01" @default.
- W2025433127 modified "2023-10-14" @default.
- W2025433127 title "Antineoplastic effect of a single oral dose of the novel Flt3 inhibitor KRN383 on xenografted human leukemic cells harboring Flt3-activating mutations" @default.
- W2025433127 cites W1486112083 @default.
- W2025433127 cites W1506423591 @default.
- W2025433127 cites W1542395305 @default.
- W2025433127 cites W1969130273 @default.
- W2025433127 cites W1971056717 @default.
- W2025433127 cites W1983999811 @default.
- W2025433127 cites W1989512056 @default.
- W2025433127 cites W1990030298 @default.
- W2025433127 cites W2004477791 @default.
- W2025433127 cites W2021493109 @default.
- W2025433127 cites W2032235066 @default.
- W2025433127 cites W2034820298 @default.
- W2025433127 cites W2041027929 @default.
- W2025433127 cites W2059499441 @default.
- W2025433127 cites W2069057374 @default.
- W2025433127 cites W2070308429 @default.
- W2025433127 cites W2071432029 @default.
- W2025433127 cites W2082408605 @default.
- W2025433127 cites W2092880883 @default.
- W2025433127 cites W2125877707 @default.
- W2025433127 cites W2129615499 @default.
- W2025433127 cites W2130864403 @default.
- W2025433127 cites W2132912591 @default.
- W2025433127 cites W2149032069 @default.
- W2025433127 cites W2153345005 @default.
- W2025433127 cites W2321946412 @default.
- W2025433127 doi "https://doi.org/10.1016/j.leukres.2006.02.028" @default.
- W2025433127 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16603240" @default.
- W2025433127 hasPublicationYear "2006" @default.
- W2025433127 type Work @default.
- W2025433127 sameAs 2025433127 @default.
- W2025433127 citedByCount "8" @default.
- W2025433127 crossrefType "journal-article" @default.
- W2025433127 hasAuthorship W2025433127A5002130016 @default.
- W2025433127 hasAuthorship W2025433127A5016021144 @default.
- W2025433127 hasAuthorship W2025433127A5017158232 @default.
- W2025433127 hasAuthorship W2025433127A5021542575 @default.
- W2025433127 hasAuthorship W2025433127A5034932811 @default.
- W2025433127 hasAuthorship W2025433127A5038129810 @default.
- W2025433127 hasAuthorship W2025433127A5042588749 @default.
- W2025433127 hasAuthorship W2025433127A5043017347 @default.
- W2025433127 hasAuthorship W2025433127A5045693486 @default.
- W2025433127 hasAuthorship W2025433127A5059619073 @default.
- W2025433127 hasAuthorship W2025433127A5062150969 @default.
- W2025433127 hasAuthorship W2025433127A5067804516 @default.
- W2025433127 hasAuthorship W2025433127A5076054400 @default.
- W2025433127 hasAuthorship W2025433127A5084554077 @default.
- W2025433127 hasAuthorship W2025433127A5085709435 @default.
- W2025433127 hasAuthorship W2025433127A5087474480 @default.
- W2025433127 hasAuthorship W2025433127A5088372604 @default.
- W2025433127 hasConcept C104317684 @default.
- W2025433127 hasConcept C121608353 @default.
- W2025433127 hasConcept C126322002 @default.
- W2025433127 hasConcept C150109051 @default.
- W2025433127 hasConcept C170493617 @default.
- W2025433127 hasConcept C176944494 @default.
- W2025433127 hasConcept C184235292 @default.
- W2025433127 hasConcept C185592680 @default.
- W2025433127 hasConcept C203014093 @default.
- W2025433127 hasConcept C2777752497 @default.
- W2025433127 hasConcept C2778461978 @default.
- W2025433127 hasConcept C2778729363 @default.
- W2025433127 hasConcept C2778820342 @default.
- W2025433127 hasConcept C42362537 @default.
- W2025433127 hasConcept C501734568 @default.
- W2025433127 hasConcept C502942594 @default.
- W2025433127 hasConcept C54355233 @default.
- W2025433127 hasConcept C55493867 @default.
- W2025433127 hasConcept C71924100 @default.
- W2025433127 hasConcept C81885089 @default.
- W2025433127 hasConcept C86803240 @default.
- W2025433127 hasConcept C97029542 @default.
- W2025433127 hasConcept C98274493 @default.
- W2025433127 hasConceptScore W2025433127C104317684 @default.
- W2025433127 hasConceptScore W2025433127C121608353 @default.
- W2025433127 hasConceptScore W2025433127C126322002 @default.